17-76391314-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_022066.4(UBE2O):c.3508G>A(p.Glu1170Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00000682 in 1,612,862 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_022066.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UBE2O | NM_022066.4 | c.3508G>A | p.Glu1170Lys | missense_variant | 18/18 | ENST00000319380.12 | NP_071349.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UBE2O | ENST00000319380.12 | c.3508G>A | p.Glu1170Lys | missense_variant | 18/18 | 1 | NM_022066.4 | ENSP00000323687.6 | ||
UBE2O | ENST00000587127.1 | c.2050G>A | p.Glu684Lys | missense_variant | 10/10 | 1 | ENSP00000468498.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000402 AC: 1AN: 249014Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135114
GnomAD4 exome AF: 0.00000685 AC: 10AN: 1460694Hom.: 0 Cov.: 37 AF XY: 0.00000550 AC XY: 4AN XY: 726702
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74336
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 29, 2024 | The c.3508G>A (p.E1170K) alteration is located in exon 18 (coding exon 18) of the UBE2O gene. This alteration results from a G to A substitution at nucleotide position 3508, causing the glutamic acid (E) at amino acid position 1170 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at